Measurement of Treatment Adherence With Antipsychotic Agents in Patients With Schizophrenia

Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s6637
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Treatment Adherence and Social Functioning in Patients Diagnosed With Schizophrenia and Treated With Antipsychotic Depot Medication

Medicine and Pharmacy Reports
Medicine
2014English

Increased Orbitofrontal Cortex Activation Associated With “Pro-Obsessive” Antipsychotic Treatment in Patients With Schizophrenia

Journal of Psychiatry and Neuroscience
MedicinePsychiatryBiological PsychiatryMental HealthPharmacology
2015English

Augmented Antipsychotic Therapy With Pantogam Active in Patients With Schizophrenia

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
PsychiatryMental HealthNeurology
2015English

Pharmacoeconomic Comparison of Ziprasidone With Other Atypical Oral Antipsychotic Agents in Schizophrenia

Farmeconomia. Health economics and therapeutic pathways
2011English

Clinical and Psychosocial Remission in Schizophrenia: Correlations With Antipsychotic Treatment

BMC Psychiatry
PsychiatryMental Health
2012English

Antipsychotic Treatment Patterns and Hospitalizations Among Adults With Schizophrenia

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2008English

Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy

BMC Psychiatry
PsychiatryMental Health
2014English

Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2018English

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia

Frontiers in Psychiatry
PsychiatryMental Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy